Slideshows, podcasts, news, videos that pertain to the Partnerships in Clinical Trials held March 6-8, 2012.
Editors' Welcome You to the ShowThis video sets the stage for the Partnerships conference and highlights the keynote presentation.
Operational ExcellenceIn this blog, the various presenters in the Partnerships’ Operational Excellence Track offer their definition of Operational Excellence.
Global Partnership Challenges
This slideshow offers an interview and short review of Andy Townshend, Vice President, Alliance Development at INC Research, presentation at Partnerships.
Conducting Clinical Trials in China
This slideshow presents insights from R. Stephen Porter, PharmD., FCP and Director and Co-founder of VDDI Pharmaceuticals and Dragon Bio-Consultants (Hong Kong) on how to conduct clinical trials in China when you are not big pharma.
What's on Tap for eClinical
This audio blog discusses the eClinical track offerings at Partnerships.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.